Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,551 | 595 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,340 | 104 | $0 (2024) |
| Novo Nordisk Inc | $817.67 | 94 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $521.69 | 19 | $0 (2024) |
| Lilly USA, LLC | $500.71 | 64 | $0 (2024) |
| Astellas Pharma US Inc | $448.57 | 22 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $397.85 | 46 | $0 (2024) |
| Amgen Inc. | $338.40 | 24 | $0 (2024) |
| PFIZER INC. | $323.42 | 35 | $0 (2024) |
| Mylan Specialty L.P. | $284.62 | 17 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $232.84 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,231 | 169 | ABBVIE INC. ($353.37) |
| 2023 | $1,803 | 151 | ABBVIE INC. ($416.85) |
| 2022 | $1,734 | 139 | ABBVIE INC. ($330.65) |
| 2021 | $1,783 | 136 | AbbVie Inc. ($238.96) |
All Payment Transactions
595 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $4.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.90 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Cardio-renal | ||||||
| 11/27/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Biological | ||||||
| 11/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.13 | General |
| Category: PAIN | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: VACCINES | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.68 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.25 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/06/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Cardio-renal | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.45 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.58 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Neuropsychiatry | ||||||
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.30 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.22 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,744 | 2,112 | $200,988 | $79,970 |
| 2022 | 27 | 1,894 | 2,153 | $190,127 | $70,923 |
| 2021 | 30 | 1,735 | 2,045 | $184,891 | $72,708 |
| 2020 | 10 | 559 | 681 | $99,930 | $33,131 |
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 326 | 503 | $106,522 | $34,589 | 32.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 169 | 169 | $32,279 | $17,501 | 54.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 148 | 198 | $29,660 | $8,942 | 30.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $6,051 | $4,214 | 69.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 42 | 42 | $4,242 | $3,021 | 71.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 193 | 256 | $3,725 | $2,134 | 57.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 111 | 113 | $3,164 | $1,456 | 46.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 130 | 133 | $2,955 | $1,377 | 46.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 103 | 132 | $2,352 | $1,257 | 53.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 136 | 148 | $1,955 | $1,126 | 57.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 47 | 53 | $1,864 | $872.38 | 46.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 44 | 44 | $836.00 | $819.28 | 98.0% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 48 | 59 | $1,062 | $489.11 | 46.1% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 25 | 26 | $1,014 | $468.52 | 46.2% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 19 | 19 | $741.00 | $359.48 | 48.5% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 36 | 40 | $760.00 | $353.60 | 46.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 15 | 15 | $285.00 | $279.30 | 98.0% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 31 | 31 | $403.00 | $175.46 | 43.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 11 | 11 | $352.00 | $162.58 | 46.2% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 31 | 31 | $279.00 | $157.48 | 56.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 32 | 37 | $190.00 | $81.40 | 42.8% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 13 | 15 | $165.00 | $76.20 | 46.2% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2023 | 19 | 22 | $132.00 | $58.30 | 44.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 299 | 383 | $80,018 | $25,372 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 214 | 308 | $45,565 | $15,111 | 33.2% |
About Robert Wollenzien
Robert Wollenzien is a Physician Assistant healthcare provider based in Salem, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2018. The National Provider Identifier (NPI) number assigned to this provider is 1831674092.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Wollenzien has received a total of $7,551 in payments from pharmaceutical and medical device companies, with $2,231 received in 2024. These payments were reported across 595 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($7,551).
As a Medicare-enrolled provider, Wollenzien has provided services to 5,932 Medicare beneficiaries, totaling 6,991 services with total Medicare billing of $256,732. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Salem, UT
- Active Since 10/03/2018
- Last Updated 11/27/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1831674092
Products in Payments
- VRAYLAR (Drug) $622.10
- Ozempic (Drug) $507.86
- UBRELVY (Drug) $396.26
- BREZTRI (Drug) $391.15
- NURTEC ODT (Drug) $350.76
- MOUNJARO (Drug) $344.55
- Veozah (Drug) $321.73
- QULIPTA (Drug) $294.80
- JARDIANCE (Drug) $274.36
- Kerendia (Drug) $232.84
- Rybelsus (Drug) $208.93
- ZENPEP (Drug) $201.11
- ELIQUIS (Drug) $198.99
- Yupelri (Drug) $182.12
- TRADJENTA (Drug) $161.01
- SOLIQUA 100/33 (Biological) $155.79
- Otezla (Drug) $150.86
- XARELTO (Drug) $119.74
- YUPELRI (Drug) $102.50
- EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) $100.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Salem
Shawn Hill, Mpas, MPAS
Physician Assistant — Payments: $16,101
Mrs. Olivia Darwin, Pa-C, PA-C
Physician Assistant — Payments: $9,122
Shannon Snyder, Pa-C, PA-C
Physician Assistant — Payments: $8,469
Eric Harmon, Pa, PA
Physician Assistant — Payments: $8,455
Jordan Young, Pa-C, PA-C
Physician Assistant — Payments: $7,356
Olivia Bartels, Pa-C, PA-C
Physician Assistant — Payments: $7,238